Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter
Clinical trial NCT00115791 · COMPLETED
Trial details
- NCT number
- NCT00115791
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2005-06-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.